OPDIVO (Nivolumab) 40mg/4mL online

$866.00

In stock

OPDIVO is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of advanced Lung Cancer, Melanoma, advanced Kidney Cancer, Head and Neck Squamous Cell Cancer, Advanced Liver Cancer, Advanced Bladder Cancer, Colorectal Cancer and Classical Hodgkin Lymphoma.

866.00 per Vial

Compare

What is Opdivo?

OPDIVO is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of advanced Lung Cancer, Melanoma, advanced Kidney Cancer, Head and Neck Squamous Cell Cancer, Advanced Liver Cancer, Advanced Bladder Cancer, Colorectal Cancer and Classical Hodgkin Lymphoma.
How much does opdivo cost:
Opdivo pricing in United States is 3839USD for 3 Vial 40mg/4mL. Opdivo 40MG/4ML cost in India is only 65% of the opdivo pricing in Untied States and Canada.
Opdivo Dosage
Administer OPDIVO as an intravenous infusion over 30 minutes.
Unresectable or metastatic melanoma
OPDIVO 240mg every 2 weeks or 480mg every 4 weeks
OPDIVO 1 mg/kg, followed by ipilimumab on the same day, every 3 weeks for 4 doses, then OPDIVO 240 mg every 2 weeks or 480 mg every 4 weeks.
Adjuvant treatment of melanoma
• OPDIVO 240 mg every 2 weeks or 480 mg every 4 weeks.
Metastatic non-small cell lung cancer
• OPDIVO 240mg every 2 weeks or 480mg every 4 weeks.
Small cell Lung cancer
• OPDIVO 240 mg every 2 weeks. (2.4) • Advanced renal cell carcinoma

OPDIVO 240mg every 2 weeks or 480mg every 4 weeks.
OPDIVO 3 mg/kg followed by ipilimumab 1 mg/kg on the same day every 3 weeks for 4 doses, then OPDIVO 240 mg every 2 weeks or 480 mg every 4 weeks.

• Classical Hodgkin lymphoma • OPDIVO (nivolumab) 240 mg every 2 weeks or 480 mg every 4 weeks.
• Recurrent or metastatic squamous cell carcinoma of the head and neck • OPDIVO 240 mg every 2 weeks or 480 mg every 4 weeks.

Locally advanced or metastatic urothelial carcinoma
OPDIVO 240mg every 2 weeks or 480 mg every 4 weeks
Microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer
OPDIVO 240 mg every 2 weeks.
OPDIVO 3 mg/kg followed by ipilimumab 1 mg/kg on the same day every 3 weeks for 4 doses, then OPDIVO 240 mg every 2 weeks.
Hepatocellular carcinoma • OPDIVO 240 mg every 2 weeks or 480 mg every 4 weeks

Opdivo review
I wanted to do a test run and BONHOA passed with flying colors. Ordering was easy. And, I was able to track the package, which showed up at my door one week later. I will be ordering a new order next week. God bless all of you!!
Nivolumab side effects:

Severe infusion reactions. Tell your doctor or nurse right away if you get these symptoms during an infusion of OPDIVO:
chills or shaking ○ dizziness ○ itching or rash ○ fever ○ flushing ○ feeling like passing out ○ difficulty breathing

● Complications of stem cell transplant that uses donor stem cells (allogeneic). These complications can be severe and can lead to death. Your healthcare provider will monitor you for signs of complications if you have an allogeneic stem cell transplant.
Nivolumab pi
For more Prescribing information,please check the → “FDA Prescribing Information”.

 

See It Styled On Instagram

    Instagram did not return any images.

Main Menu